Evidence map›Paper›PMID 40733688›Full record

ArticleVaccines2025

Measles Epidemiology and Coverage of Immunization Against Measles in the Autonomous Province of Vojvodina, Serbia: Local Trends in a Regional Context.

Mioljub Ristić, Svetlana Ilić, Smiljana Rajčević, Mirjana Štrbac, Snežana Medić, Tatjana Pustahija, Vladimir Vuković, Marko Koprivica, Gorana Dragovac, Vladimir Petrović

Abstract read
In one paragraph

Article in Vaccines, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Mioljub RistićInstitute of Public Health of Vojvodina, 21000 Novi Sad, Serbia.ORCID 0000-0002-6923-189X
Svetlana IlićInstitute of Public Health of Vojvodina, 21000 Novi Sad, Serbia.
Smiljana RajčevićInstitute of Public Health of Vojvodina, 21000 Novi Sad, Serbia.
Mirjana ŠtrbacInstitute of Public Health of Vojvodina, 21000 Novi Sad, Serbia.ORCID 0000-0003-1532-5548
Snežana MedićInstitute of Public Health of Vojvodina, 21000 Novi Sad, Serbia.
Tatjana PustahijaInstitute of Public Health of Vojvodina, 21000 Novi Sad, Serbia.
Vladimir VukovićInstitute of Public Health of Vojvodina, 21000 Novi Sad, Serbia.ORCID 0000-0002-9561-7825
Marko KoprivicaInstitute of Public Health of Vojvodina, 21000 Novi Sad, Serbia.
Gorana DragovacInstitute of Public Health of Vojvodina, 21000 Novi Sad, Serbia.
Vladimir PetrovićInstitute of Public Health of Vojvodina, 21000 Novi Sad, Serbia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDespite ongoing global elimination efforts, measles remains a persistent public health threat.

methodsThis retrospective observational study examines trends in crude measles incidence and vaccination coverage from 1948 to 2024 in the northern region of Serbia-Autonomous Province of Vojvodina (AP Vojvodina)-which accounts for 26.9% of the national population. This study further explores measles vaccination coverage across the province's seven districts, along with the number of reported measles cases, age distribution, and vaccination status of affected individuals from 2000 to 2024. Data were obtained from official annual immunization records maintained by public health institutions within the framework of Serbia's national mandatory immunization program.

resultsA notable resurgence of measles occurred in Serbia during 2017-2018, following a decline in vaccination coverage. In AP Vojvodina, outbreaks were recorded in 2007, 2014-2015, and 2017-2018, predominantly affecting unvaccinated children and adults aged 20-39 years. Since 2019, the measles incidence has significantly declined. During the 2018 outbreak, the highest incidence was observed among children aged 1-4 years (40.6 per 100,000), followed by infants under 1 year (17.3 per 100,000) and adults aged 20-39 years (12.5 per 100,000). An analysis of the data from 2000 to 2024 revealed substantial age- and dose-related differences in measles incidence, particularly among unvaccinated individuals, those who had received one or two doses of a measles-containing vaccine (MCV), and those with unknown vaccination status. During the 2017-2018 epidemic, unvaccinated children under 1 year and those aged 1-4 years were the most affected. A marked increase in cases among single-dose recipients was noted in 2018, especially in adults aged 20-39 years (9.5%) and those ≥40 years (13.5%). A considerable proportion of measles cases in these age groups had unknown vaccination status: 33.1% among individuals aged 20-39 years and 18.2% among those aged ≥ 40 years. Epidemiological investigation linked the 2007 and 2014-2015 outbreaks in AP Vojvodina to importations from Bosnia and Herzegovina. No specific source was identified for the 2017-2018 outbreak, suggesting possible endemic transmission.

conclusionsThese findings underscore the impact of fluctuating vaccination coverage on measles resurgence. Sustaining high two-dose MCV coverage, strengthening routine immunization programs, enhancing surveillance systems, and ensuring timely outbreak preparedness are critical measures for achieving effective measles control.

Indexed as

AP Vojvodinaepidemiologyherd immunityimmunization programsmeaslesoutbreaksSerbiavaccination coverage

Identifiers

PMID40733688
PMCPMC12300201

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.